SUVEN PHARMACEUTICALS LIMITED financial statements, including revenue, expenses, profit, and loss
The total revenue of SUVENPHAR for the last quarter is 2.20 B INR, and it's 4.86% lower compared to the previous quarter. The net income of Q3 23 is 467.54 M INR.